Breakthrough Genomics
PrivateCompany Overview
Breakthrough Genomics is a healthcare technology company that provides AI-powered genomic data analysis and clinical interpretation software for rare disease diagnosis and cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breakthrough Genomics Comparables
Compare Breakthrough Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomenon Inc. | 84% | |
| Golden Helix | 83% | |
| Gamow Labs, Inc. | 82% |
Breakthrough Genomics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 990% MoM, reaching 1.7K.
- Nov 12, 2024
Monthly visitors grew 1150% MoM, reaching 1.3K.
Breakthrough Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Breakthrough Genomics's valuation, stock price, and market status.
Is Breakthrough Genomics a public or private company?
Breakthrough Genomics is a private company.
What is the current stock price of Breakthrough Genomics?
Breakthrough Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Breakthrough Genomics worth (valuation)?
Valuation information for Breakthrough Genomics is not publicly available.
Can I buy Breakthrough Genomics stock?
Breakthrough Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Breakthrough Genomics's last funding round?
Funding round information for Breakthrough Genomics is not publicly available.
Who are the main investors in Breakthrough Genomics?
Investor information for Breakthrough Genomics is not publicly disclosed.
Will Breakthrough Genomics IPO soon?
No public IPO plans have been announced for Breakthrough Genomics.
How can I track Breakthrough Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Breakthrough Genomics's secondary market activity and sign up for updates.